McKesson Corporation is transforming from a traditional distributor to a tech-enabled healthcare services leader, focusing on high-margin specialty and digital solutions. Recent acquisitions (PRISM ...

McKesson Corporation is rated 'Buy' due to its transformation into a higher-growth, higher-margin healthcare services platform focused on Oncology & Multispecialty and Prescription Technology ...

Sept 23 (Reuters) - McKesson (MCK.N), opens new tab on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth ...

Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 6.6% in the morning session after the company raised its profit forecast for fiscal 2026 and boosted its long-term ...

IRVING, Texas, September 23, 2025--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss ...

McKesson plans changes to its organizational structure as looks to boost growth in the higher-margin areas of its portfolio such as oncology, multispecialty and biopharma services. The ...

Walmart Inc. is working with the only U.S. maker of amoxicillin and a pharmaceutical distributor of the antibiotic to supply Walmart pharmacies as well as other health care providers nationwide.

Stripping away decades of precedence and standardized regulation makes compliance a moving target — especially for lenders whose operations span state borders — yet this is exactly what happened ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PACS Group Inc ( (PACS)) has provided an ...

Deal Rationale McKesson’s strategic focus on disciplined portfolio management involves continuous evaluation of its business segments to ensure alignment with its growth priorities and optimize ...